Canton Strategic

CNTNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$144.219 M

$1.87 +0.54%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$35.9M

Loss-making

Shares outstanding

56,656,271

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#282Jyong BiotechMENS$154.3M
#283Milestone PharmaceuticalsMIST$151.9M
#284Canton StrategicCNTN$144.2M
#285ADC TherapeuticsADCT$143.7M
#286Nervgen PharmaNGEN$140.6M

Where these numbers come from

Share counts and financials for Canton Strategic are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.